CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy
- 1 March 2004
- journal article
- clinical trial
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 27 (2) , 229-240
- https://doi.org/10.1023/b:boli.0000028794.04349.91
Abstract
Summary: We report the clinical and radiological central nervous system (CNS) findings of 8 Fabry disease patients, before (8/8) and after (7/8) 12 months of enzyme replacement therapy (ERT) with aga...Keywords
This publication has 18 references indexed in Scilit:
- Proton MR Spectroscopy of Polymicrogyria and Heterotopia2003
- Proton MR Spectroscopy in Mild Cognitive Impairment and Alzheimer Disease: Comparison of 1.5 and 3 T2003
- Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement TherapyAnnals of Internal Medicine, 2003
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- Regional Cerebral Hyperperfusion and Nitric Oxide Pathway Dysregulation in Fabry DiseaseCirculation, 2001
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001
- Fabry Disease (α-Galactosidase A Deficiency)Published by Elsevier ,2001
- Cerebrovascular complications of Fabry's diseaseAnnals of Neurology, 1996